Giorgina Mangano

This inventor holds 24 USPTO granted patents and 1 published patent application, plus 5 CIPO patents and 16 EPO patents, primarily in Pharmaceutical Compounds. Top assignee: Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a.. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giorgina Mangano. Retrieved from https://idiyas.com/inventor/giorgina-mangano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 1)

% Patents Active = 8.3

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 16 (Patent Applications = 14)

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 57(Granted Patents)

Company Filing History:

24 out of 106

Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a.

patents

Years Active: 2011-2025

Loading Chart...

Areas of Expertise:

Antibacterial Compounds

Peptides

CGRP

Acetylcholine

Indazole Derivatives

Pharmaceutical Composition

MCP-1

CX3CR1

3-Aminocarbazole

Muscarinic Receptor

Broad Spectrum Activity

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12377035 - Peptides for inhibiting cholinergic calcitonin gene-related peptide (CGRP) and acetylcholine (ACH) release or inhibiting sensitization-mediated by TRPV1-mediated excitability in sensory neurons and methods of use thereof (2025-08-05),

2. 12102705 - Peptides having inhibitory activity on muscarinic receptor M3 (2024-10-01),

3. 10640488 - Antibacterial compounds (2020-05-05),

4. 10633366 - Antibacterial compounds (2020-04-28),

5. 10369130 - Antibacterial compounds (2019-08-06),

6. 10221144 - Antibacterial compounds having broad spectrum of activity (2019-03-05),

7. 10005730 - 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor (2018-06-26),

8. 9655906 - Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it (2017-05-23),

9. 9255073 - 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40 (2016-02-09),

10. 9249097 - 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor (2016-02-02),

11. 9120801 - Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it (2015-09-01),

12. 8871948 - (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor (2014-10-28),

13. 8835481 - 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40 (2014-09-16),

14. 8686021 - [object Object] (2014-04-01),

15. 8637682 - 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor (2014-01-28),

Title: The Innovative Contributions of Giorgina Mangano

Introduction: Giorgina Mangano, an esteemed inventor based in Rome, Italy, boasts a remarkable portfolio of 23 patents. Her work primarily focuses on groundbreaking innovations in the fields of pharmaceutical and cosmetic products, driven by a commitment to improving health and well-being.

Latest Patents: Among Giorgina's notable inventions are two recent patents that exemplify her innovative spirit. The first, titled "Peptides having inhibitory activity on muscarinic receptor M3," details the development of peptides capable of inhibiting muscarinic receptor M3 activity. These peptides have significant potential applications in pharmaceutical and cosmetic products aimed at alleviating skin conditions mediated by this receptor, including excessive perspiration, inflammation, and excessive sebum production. The second patent, concerning "Antibacterial compounds," pertains to novel antibacterial agents and the pharmaceutical compositions that contain them, emphasizing their effectiveness as antimicrobials.

Career Highlights: Throughout her career, Giorgina Mangano has made significant strides in research and development. Her expertise has led her to contribute to numerous innovations in the life sciences arena. She has held positions in renowned companies such as Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A., where her work has garnered attention for its scientific rigor and applicability.

Collaborations: Throughout her professional endeavors, Giorgina has collaborated with distinguished colleagues, including Guido Furlotti and Nicola Cazzolla. These partnerships have fostered a creative environment conducive to breakthroughs in their respective fields, enhancing the development of innovative solutions grounded in research.

Conclusion: Giorgina Mangano's contributions to the domains of pharmaceuticals and cosmetics highlight her as a prominent figure in innovation. Her extensive patent portfolio is a testament to her dedication to developing impactful solutions that address pressing health-related challenges. With ongoing research and collaboration, Giorgina continues to pave the way for future advancements that improve lives around the globe.

Profile summary based on public USPTO records.